BT8009-230
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BT8009-230, covering 2026-04-22 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) [Phase 2, Phase 3]